NCT06024005View on ClinicalTrials.gov

Comparison of the Transcutaneous Tibial Nerve Stimulation and Drug Treatment' Effects in Women With Overactive Bladder

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

April 18, 2023

Primary Completion Date

May 24, 2023

Study Completion Date

May 24, 2023

Conditions
Overactive BladderOveractive Bladder Syndrome
Interventions
DRUG

Oral Solifenacin 5mg

Oral solifenacin (Kinzy 5mg) use once a day for 6 weeks

DEVICE

Transcutaneous Posterior Tibial Nerve Stimulation (TTNS)

Application of TTNS twice a week for 6 weeks, with each session for 30 minutes

Trial Locations (1)

35100

Ege University, School of Medicine, Department of Obstetrics and Gynecology, Izmir

All Listed Sponsors
lead

Ege University

OTHER